GB
Therapeutic Areas
Analona Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Undisclosed Metabolic Disruptor | High medical need solid tumors | Preclinical |
Leadership Team at Analona Therapeutics
AB
Axel Behrens
Chief Scientific Officer and Co-founder
MW
Mikkel Wandahl Pedersen
Co-founder and Advisor